Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2008
10/02/2008US20080242701 Antitumor agents; anticancer agents; cytotoxic activity; angiogenesis inhibitor; leukemia; colorectal cancer; administering by mouth
10/02/2008US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis
10/02/2008US20080242696 Mixing with a solvent and heating
10/02/2008US20080242693 dopamine and nicotinic acetylcholine receptors antagonist; analgesic, antidepressant, anxiolytic agent; neurodegenerative diseases, drug and nicotine abuse, obesity; 6-(5-methoxy-3-pyridinyl)-3-azabicyclo[3.3.1]non-6-ene
10/02/2008US20080242677 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one
10/02/2008US20080242676 Drug resistant Mycobacterium tuberculosis
10/02/2008US20080242675 Prevent transplant rejection
10/02/2008US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
10/02/2008US20080242666 e.g. (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-1-[2(hydroxymethyl)benzyl]-piperazine-2,5-dione; preparation by cyclization
10/02/2008US20080242660 1,4-diazepin-1-sulfonyl-isoquinoline derivatives; Rho kinase, myosin light chain kinase or protein kinase C inhibitor; relaxing effect on vascular smooth muscles; hypotensive and vasodilating agent; occlusion or stenosis of an artery
10/02/2008US20080242658 Inhibitors of Iap
10/02/2008CA2682012A1 Substituted pyrrolidinamides, manufacturing and use thereof as medicaments
10/02/2008CA2681718A1 Hiv-1 protease inhibitors
10/02/2008CA2681206A1 8-(heteroarylmethoxy)quinoline compounds as bradykinin b2 receptor modulators
10/02/2008CA2681030A1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/01/2008EP1975168A1 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
10/01/2008EP1975167A1 Acetone solvate of phthaloyl amlodipine
10/01/2008EP1975166A1 Synthesis of anthranilamides
10/01/2008EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles
10/01/2008EP1975153A2 Protease inhibitors
10/01/2008EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/01/2008EP1973905A1 Compounds
10/01/2008EP1973897A2 Substituted pyrymidine derivatives useful in the treatment of cancer and other disorders
10/01/2008EP1973896A1 A process for the preparation of the (s)-enantiomer of omeprazole
10/01/2008EP1973888A1 Isoxazolines for controlling invertebrate pests
10/01/2008EP1973886A2 Prokineticin 1 receptor antagonists
10/01/2008EP1973884A2 Novel heterocycles
10/01/2008EP1973882A1 Piperazine derivatives as farnesyl protein transferase inhibitors
10/01/2008EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
10/01/2008CN101277949A Dipeptidyl peptidase-iv inhibitors
10/01/2008CN101277948A Chemical process
10/01/2008CN101277947A 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(l-methylpiperidin-4-ylmethoxy) quinazoline monohydrate
10/01/2008CN101277946A Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
10/01/2008CN101277945A Indol-3-yl-carbonyl-piperidin and piperazin derivatives
10/01/2008CN101277934A Metabotropic glutamate-receptor-potentiating isoindolones
10/01/2008CN101274932A 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/01/2008CN101274931A Preparing process for rupatadine
10/01/2008CN101274930A 1-(8-chinoline)-3(2-pyridine)-triazene, preparation thereof and application thereof
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN101274928A 3-substituted-4-pyrimidone derivatives
10/01/2008CN101274918A Substitutive five membered heterocyclic compound, preparation and medical use thereof
10/01/2008CN100422177C Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
10/01/2008CN100422175C 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
10/01/2008CN100422174C Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422171C Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/01/2008CN100422170C Process for porducing quinolonecarboxylic acid derivative
10/01/2008CN100422158C Inhibitors of Akt activity
10/01/2008CN100422156C Isoquinolinium compound, producing method and application of its salt
10/01/2008CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/01/2008CN100421665C Mitotic kinesin inhibitors
10/01/2008CA2654898A1 New chemical compounds
09/2008
09/30/2008US7429667 suc as 5-[4-(2,5-Dichloro-phenoxy)-3-fluoro-phenylamino]-3-hydroxy-N-isopropyl-isothiazole-4-carboxamidine; anticarcinogenic agent
09/30/2008US7429659 Isopropyl-piperazin-1-yl)-(5-piperidin-1-ylmethyl-furan-2-yl)-methanone; 5-(4-Fluoro-piperidin-1-ylmethyl)-furan-2-yl]-(4-isopropyl-piperazin-1-yl)-methanone, fumarate salt; insomnia, attention deficit hyperactivity disorders, learning disorders, cognitive dysfunction, eating disorders, obesity
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429605 Phenylpyridine derivatives
09/30/2008US7429604 Six-membered heterocycles useful as serine protease inhibitors
09/30/2008US7429603 C-fms kinase inhibitors
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
09/30/2008US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors
09/30/2008US7429594 Substituted heterocyclic compounds and methods of use
09/30/2008US7429593 Utilities of amide compounds
09/30/2008US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
09/30/2008US7429590 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders
09/30/2008US7429581 Pyrazole-derivatives as factor Xa inhibitors
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/30/2008CA2338220C Substituted imidazoles having cytokine inhibitory activity
09/30/2008CA2314009C Triazole and imidazole derivatives
09/30/2008CA2303848C Substituted anilides
09/30/2008CA2274076C Crystalline form of s-omeprazole
09/25/2008WO2008116185A2 Substituted pyrimidines as adenosine receptor antagonists
09/25/2008WO2008115738A1 Chemical compounds
09/25/2008WO2008115719A1 Fused amino pyridine as hsp90 inhibitors
09/25/2008WO2008115593A1 1-[(2'-substituted)-piperazin-1'-yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
09/25/2008WO2008115381A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/25/2008WO2008115369A2 Inhibitors of focal adhesion kinase
09/25/2008WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders
09/25/2008WO2008114971A1 Novel benzamide derivatives and process for the preparation thereof
09/25/2008WO2008114812A1 Jak inhibitor
09/25/2008WO2008114023A2 Phthalazinone derivatives
09/25/2008WO2008114002A1 Quinoline derivatives for the treatment of inflammatory diseases
09/25/2008WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/25/2008WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes
09/25/2008WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
09/25/2008WO2008097428A3 Compounds and compositions as modulators of gpr119 activity
09/25/2008WO2008086128A3 Aminopyrazole kinase inhibitors
09/25/2008WO2008067399A3 Controlled-release multi-layer formulation of piperazine-piperidine antagonists and agonists of the 5-th1a receptor having enhanced intestinal dissolution
09/25/2008WO2008060391A3 2- [l-phenyl-5-hydr0xy-4alpha-methyl-hexahydr0cycl0penta[f] indaz0l-5-yl] ethyl phenyl derivatives as glucocorticoid receptor ligands
09/25/2008WO2008046919A3 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 1080